{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T20:49:27Z","timestamp":1782852567901,"version":"3.54.5"},"reference-count":40,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/501100004704","name":"National Research Council of Thailand","doi-asserted-by":"crossref","award":["N42A650265"],"award-info":[{"award-number":["N42A650265"]}],"id":[{"id":"10.13039\/501100004704","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Science Progress"],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:p>\n                    <jats:bold>Objective:<\/jats:bold>\n                    Combining calcium with citrate clinically prevents the formation of calcium oxalate (CaOx) stones. In this study, we developed a new method for measuring calcium citrate (CalCit) precipitated out of urine samples.\n                    <jats:bold>Method:<\/jats:bold>\n                    CalCit in urine was formed by challenging with excessive calcium and precipitated out by ethanol. The precipitated CalCit (pCalCit) was redissolved and measured by an indicator displacement assay (IDA) using murexide as an indicator. This method is called the murexide-based IDA for measurement of precipitated CalCit (miDA-pCalCit).\n                    <jats:bold>Results:<\/jats:bold>\n                    Urea, creatinine, ammonia, sulfate, carbonate, uric acid, oxalate, albumin, and bilirubin did not interfere with the pCalCit measurement. The limit of detection and limit of quantitation were 80 and 400\u2005\u03bcM, respectively. The miDA-pCalCit test was clinically validated in 24-hour urine samples obtained from CaOx stone patients and nonstone forming (NSF) subjects. The urinary pCalCit levels of CaOx stone patients were significantly lower than NSF subjects. Receiver operating characteristic analysis revealed an area under curve of 0.823 (95% confidence interval [CI]: 0.752\u20130.893) for separating CaOx stone patients from NSF subjects. At the cutoff of 632 \u00b5M, the test provided sensitivity, specificity, positive predictive value, negative predictive value, positive likelihood ratio, negative likelihood ratio (LH\u2212), and accuracy of 84.4%, 70.1%, 51.4%, 92.5%, 2.9, 0.2, and 74.3%, respectively.\n                    <jats:bold>Conclusions:<\/jats:bold>\n                    We successfully established the miDA-pCalCit test for measuring pCalCit in 24-hour urine samples. The urinary pCalCit levels in CaOx stone patients decreased significantly compared with NSF individuals. With an LH\u2212 of 0.2, the negative test result could be clinically helpful for ruling out CaOx urolithiasis.\n                  <\/jats:p>","DOI":"10.1177\/00368504251363660","type":"journal-article","created":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T12:00:36Z","timestamp":1775476836000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Measurement of precipitated calcium citrate in 24-hour urine samples is clinically useful for ruling out calcium oxalate urolithiasis"],"prefix":"10.1177","volume":"109","author":[{"given":"Chaiyadol","family":"Tantasith","sequence":"first","affiliation":[{"name":"Chulalongkorn University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praween","family":"Tubsaeng","sequence":"additional","affiliation":[{"name":"Mahasarakham Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamonchat","family":"Boonkam","sequence":"additional","affiliation":[{"name":"Chulalongkorn University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natcha","family":"Madared","sequence":"additional","affiliation":[{"name":"Chulalongkorn University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6515-4321","authenticated-orcid":false,"given":"Chanchai","family":"Boonla","sequence":"additional","affiliation":[{"name":"Chulalongkorn University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,4,6]]},"reference":[{"key":"e_1_3_2_2_2","volume-title":"Reactive oxygen Species (ROS) in living cells","author":"Chanchai B","year":"2018","unstructured":"Chanchai B. Oxidative stress in urolithiasis. In: Cristiana F, Elena A (eds) Reactive oxygen Species (ROS) in living cells. Rijeka: IntechOpen, 2018, Ch. 8."},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.8"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-2042.2007.01953.x"},{"key":"e_1_3_2_5_2","first-page":"182","article-title":"Urinary citrate and renal stone disease: the preventive role of alkali citrate treatment","volume":"81","author":"Caudarella R","year":"2009","unstructured":"Caudarella R, Vescini F. Urinary citrate and renal stone disease: the preventive role of alkali citrate treatment. Arch Ital Urol Androl 2009; 81: 182\u2013187.","journal-title":"Arch Ital Urol Androl"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00240-002-0272-3"},{"key":"e_1_3_2_7_2","first-page":"381","article-title":"Effects of citrate on the different phases of calcium oxalate crystallization","volume":"7","author":"Tiselius HG","year":"1993","unstructured":"Tiselius HG, Berg C, Fornander AM, et al. Effects of citrate on the different phases of calcium oxalate crystallization. Scanning Microsc 1993; 7: 381\u2013389. discussion 389\u2013390.","journal-title":"Scanning Microsc"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.55.3.242"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)52618-X"},{"key":"e_1_3_2_10_2","first-page":"371","article-title":"Citrate and renal calculi: an update","volume":"20","author":"Pak CY","year":"1994","unstructured":"Pak CY. Citrate and renal calculi: an update. Miner Electrolyte Metab 1994; 20: 371\u2013377.","journal-title":"Miner Electrolyte Metab"},{"key":"e_1_3_2_11_2","first-page":"51","article-title":"Comparison of urinary citrate between patients with nephrolithiasis and healthy controls","volume":"53","author":"Saepoo S","year":"2009","unstructured":"Saepoo S, Adstamongkonkul D, Tosukhowong P, et al. Comparison of urinary citrate between patients with nephrolithiasis and healthy controls. Chula Med J 2009; 53: 51\u201365.","journal-title":"Chula Med J"},{"key":"e_1_3_2_12_2","first-page":"605","article-title":"Hypocitraturia and hypokaliuria: major metabolic risk factors for kidney stone disease","volume":"50","author":"Youngjermchan P","year":"2006","unstructured":"Youngjermchan P, Pumpaisanchai S, Ratchanon S, et al. Hypocitraturia and hypokaliuria: major metabolic risk factors for kidney stone disease. Chula Med J 2006; 50: 605\u2013621.","journal-title":"Chula Med J"},{"key":"e_1_3_2_13_2","first-page":"134","article-title":"Hypocitraturia: pathophysiology and medical management","volume":"11","author":"Zuckerman JM","year":"2009","unstructured":"Zuckerman JM, Assimos DG. Hypocitraturia: pathophysiology and medical management. Rev Urol 2009; 11: 134\u2013144.","journal-title":"Rev Urol"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1211\/jpp.59.11.0004"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(12)80635-4"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1258\/0004563054889963"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1080\/21655979.2016.1226656"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1039\/C9CS00538B"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1039\/D2AY01648F"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1080\/03067319.2019.1610172"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-012799"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ab.2010.03.031"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-811762-0.00004-9"},{"key":"e_1_3_2_24_2","article-title":"Limit of blank, limit of detection and limit of quantitation","volume":"29","author":"Armbruster DA","year":"2008","unstructured":"Armbruster DA, Pry T. Limit of blank, limit of detection and limit of quantitation. Clin Biochem Rev 2008; 29: S49\u2013S52.","journal-title":"Clin Biochem Rev"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-65244-1"},{"key":"e_1_3_2_26_2","first-page":"262","article-title":"Calcium oxalate crystallization index (COCI): an alternative method for distinguishing nephrolithiasis patients from healthy individuals","volume":"44","author":"Yang B","year":"2014","unstructured":"Yang B, Dissayabutra T, Ungjaroenwathana W, et al. Calcium oxalate crystallization index (COCI): an alternative method for distinguishing nephrolithiasis patients from healthy individuals. Ann Clin Lab Sci 2014; 44: 262\u2013271.","journal-title":"Ann Clin Lab Sci"},{"key":"e_1_3_2_27_2","first-page":"307","article-title":"Receiver operating characteristic (ROC) methodology: the state of the art","volume":"29","author":"Hanley JA","year":"1989","unstructured":"Hanley JA. Receiver operating characteristic (ROC) methodology: the state of the art. Crit Rev Diagn Imaging 1989; 29: 307\u2013335.","journal-title":"Crit Rev Diagn Imaging"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1086\/428577"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X9401400210"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1994.03510330081039"},{"key":"e_1_3_2_31_2","first-page":"257","article-title":"Citrate and renal calculi","volume":"13","author":"Pak CY","year":"1987","unstructured":"Pak CY. Citrate and renal calculi. Miner Electrolyte Metab 1987; 13: 257\u2013266.","journal-title":"Miner Electrolyte Metab"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2006.06.008"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/33.7.1259a"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12894-023-01310-w"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.3390\/ma12091565"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1002\/star.201800065"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.22487\/j24775185.2021.v10.i1.pp53-58"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1002\/jsfa.1994"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13258-018-0702-4"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0001-2998(78)80014-2"},{"key":"e_1_3_2_41_2","first-page":"65","article-title":"Urinary citrate in kidney stone disease","volume":"28","author":"Usui Y","year":"2003","unstructured":"Usui Y, Matsuzaki S, Matsushita K, et al. Urinary citrate in kidney stone disease. Tokai J Exp Clin Med 2003; 28: 65\u201370.","journal-title":"Tokai J Exp Clin Med"}],"container-title":["Science Progress"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/00368504251363660","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/00368504251363660","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/00368504251363660","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T19:47:37Z","timestamp":1782848857000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/00368504251363660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10.1177\/00368504251363660"],"URL":"https:\/\/doi.org\/10.1177\/00368504251363660","relation":{},"ISSN":["0036-8504","2047-7163"],"issn-type":[{"value":"0036-8504","type":"print"},{"value":"2047-7163","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4]]},"article-number":"00368504251363660"}}